David Henry Mack - Mar 3, 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ Robert Ticktin, by power of attorney
Stock symbol
PMVP
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/5/2025, 06:30 PM
Previous filing
Jan 22, 2025
Next filing
Jul 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PMVP Common Stock 579K Mar 3, 2025 Direct F1
holding PMVP Common Stock 165K Mar 3, 2025 See footnote F2
holding PMVP Common Stock 148K Mar 3, 2025 See footnote F3
holding PMVP Common Stock 57K Mar 3, 2025 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Award $0 +800K $0.00 800K Mar 3, 2025 Common Stock 800K $1.32 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 27,097 shares acquired under the Issuer's Employee Stock Purchase Plan as follows: 2,777 shares acquired on May 20, 2021; 2,560 shares acquired on November 21, 2022; 10,023 shares acquired on November 20, 2023 and 11,737 shares acquired on November 20, 2024.
F2 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F5 Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.